Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Researched For AOD-9604 has been studied in vitro and in animal models for its influence on lipolytic pathways in fat cells, with researchers investigating how the peptide fragment interacts with adrenergic signaling to affect lipid mobilization
Neither route is proven better in people
GLP-1 receptor agonists and gallbladder disease risk
Early research is mostly preclinical, so it should not be treated as a proven anti-aging or fat-loss treatment
Clinical trials used doses as high as 1 mg per day without safety concerns, but 300 mcg is the most commonly referenced dose in peptide medicine literature and in the investigational protocols that have been published since the formal trials concluded
Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines
US$ 26.99
US$ 27.52
US$ 24.27
US$ 25.10
US$ 28.73
US$ 21.79
US$ 25.05
